GIVAUDAN-REG (GIN.DE) Fundamental Analysis & Valuation

FRA:GIN • CH0010645932

3403 EUR
+4 (+0.12%)
Last: Jan 23, 2026, 07:00 PM

This GIN.DE fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

Fundamental Rating

6

Overall GIN gets a fundamental rating of 6 out of 10. We evaluated GIN against 67 industry peers in the Chemicals industry. GIN scores excellent on profitability, but there are some minor concerns on its financial health. GIN is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

9

1. GIN.DE Profitability Analysis

1.1 Basic Checks

  • GIN had positive earnings in the past year.
  • In the past year GIN had a positive cash flow from operations.
  • GIN had positive earnings in each of the past 5 years.
  • In the past 5 years GIN always reported a positive cash flow from operatings.
GIN.DE Yearly Net Income VS EBIT VS OCF VS FCFGIN.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

1.2 Ratios

  • With an excellent Return On Assets value of 9.70%, GIN belongs to the best of the industry, outperforming 91.55% of the companies in the same industry.
  • GIN's Return On Equity of 26.64% is amongst the best of the industry. GIN outperforms 95.77% of its industry peers.
  • Looking at the Return On Invested Capital, with a value of 14.53%, GIN belongs to the top of the industry, outperforming 94.37% of the companies in the same industry.
  • The Average Return On Invested Capital over the past 3 years for GIN is above the industry average of 6.88%.
  • The 3 year average ROIC (11.27%) for GIN is below the current ROIC(14.53%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 9.7%
ROE 26.64%
ROIC 14.53%
ROA(3y)8.16%
ROA(5y)7.72%
ROE(3y)22.13%
ROE(5y)21.72%
ROIC(3y)11.27%
ROIC(5y)10.89%
GIN.DE Yearly ROA, ROE, ROICGIN.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15 20

1.3 Margins

  • Looking at the Profit Margin, with a value of 14.51%, GIN belongs to the top of the industry, outperforming 92.96% of the companies in the same industry.
  • In the last couple of years the Profit Margin of GIN has grown nicely.
  • GIN has a better Operating Margin (18.93%) than 90.14% of its industry peers.
  • In the last couple of years the Operating Margin of GIN has grown nicely.
  • Looking at the Gross Margin, with a value of 44.13%, GIN is in line with its industry, outperforming 59.15% of the companies in the same industry.
  • GIN's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 18.93%
PM (TTM) 14.51%
GM 44.13%
OM growth 3Y4.7%
OM growth 5Y4.36%
PM growth 3Y6.18%
PM growth 5Y5.38%
GM growth 3Y1.09%
GM growth 5Y1.59%
GIN.DE Yearly Profit, Operating, Gross MarginsGIN.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30 40

5

2. GIN.DE Health Analysis

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so GIN is creating value.
  • GIN has about the same amout of shares outstanding than it did 1 year ago.
  • Compared to 5 years ago, GIN has about the same amount of shares outstanding.
  • Compared to 1 year ago, GIN has an improved debt to assets ratio.
GIN.DE Yearly Shares OutstandingGIN.DE Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M
GIN.DE Yearly Total Debt VS Total AssetsGIN.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B 10B

2.2 Solvency

  • GIN has an Altman-Z score of 4.47. This indicates that GIN is financially healthy and has little risk of bankruptcy at the moment.
  • GIN has a Altman-Z score of 4.47. This is amongst the best in the industry. GIN outperforms 84.51% of its industry peers.
  • The Debt to FCF ratio of GIN is 4.31, which is a neutral value as it means it would take GIN, 4.31 years of fcf income to pay off all of its debts.
  • GIN has a Debt to FCF ratio of 4.31. This is amongst the best in the industry. GIN outperforms 84.51% of its industry peers.
  • A Debt/Equity ratio of 0.91 indicates that GIN is somewhat dependend on debt financing.
  • The Debt to Equity ratio of GIN (0.91) is worse than 74.65% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.91
Debt/FCF 4.31
Altman-Z 4.47
ROIC/WACC3.21
WACC4.52%
GIN.DE Yearly LT Debt VS Equity VS FCFGIN.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B

2.3 Liquidity

  • A Current Ratio of 1.38 indicates that GIN should not have too much problems paying its short term obligations.
  • GIN has a worse Current ratio (1.38) than 69.01% of its industry peers.
  • GIN has a Quick Ratio of 1.38. This is a bad value and indicates that GIN is not financially healthy enough and could expect problems in meeting its short term obligations.
  • GIN's Quick ratio of 0.85 is on the low side compared to the rest of the industry. GIN is outperformed by 67.61% of its industry peers.
Industry RankSector Rank
Current Ratio 1.38
Quick Ratio 0.85
GIN.DE Yearly Current Assets VS Current LiabilitesGIN.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B

3

3. GIN.DE Growth Analysis

3.1 Past

  • The Earnings Per Share has been growing slightly by 4.21% over the past year.
  • The Earnings Per Share has been growing slightly by 6.04% on average over the past years.
  • The Revenue has been growing slightly by 5.93% in the past year.
  • Measured over the past years, GIN shows a small growth in Revenue. The Revenue has been growing by 3.63% on average per year.
EPS 1Y (TTM)4.21%
EPS 3Y11.12%
EPS 5Y6.04%
EPS Q2Q%0.69%
Revenue 1Y (TTM)5.93%
Revenue growth 3Y3.51%
Revenue growth 5Y3.63%
Sales Q2Q%3.4%

3.2 Future

  • The Earnings Per Share is expected to grow by 4.41% on average over the next years.
  • The Revenue is expected to grow by 4.33% on average over the next years.
EPS Next Y3.35%
EPS Next 2Y3.34%
EPS Next 3Y4.29%
EPS Next 5Y4.41%
Revenue Next Year1.48%
Revenue Next 2Y2.36%
Revenue Next 3Y3.19%
Revenue Next 5Y4.33%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
GIN.DE Yearly Revenue VS EstimatesGIN.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2B 4B 6B 8B
GIN.DE Yearly EPS VS EstimatesGIN.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 50 100 150

3

4. GIN.DE Valuation Analysis

4.1 Price/Earnings Ratio

  • A Price/Earnings ratio of 24.94 indicates a rather expensive valuation of GIN.
  • GIN's Price/Earnings is on the same level as the industry average.
  • The average S&P500 Price/Earnings ratio is at 26.45. GIN is around the same levels.
  • GIN is valuated rather expensively with a Price/Forward Earnings ratio of 23.44.
  • GIN's Price/Forward Earnings is on the same level as the industry average.
  • When comparing the Price/Forward Earnings ratio of GIN to the average of the S&P500 Index (24.65), we can say GIN is valued inline with the index average.
Industry RankSector Rank
PE 24.94
Fwd PE 23.44
GIN.DE Price Earnings VS Forward Price EarningsGIN.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40 50

4.2 Price Multiples

  • 70.42% of the companies in the same industry are cheaper than GIN, based on the Enterprise Value to EBITDA ratio.
  • 66.20% of the companies in the same industry are more expensive than GIN, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 25.91
EV/EBITDA 18.5
GIN.DE Per share dataGIN.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 200 400 600 800

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
  • GIN has an outstanding profitability rating, which may justify a higher PE ratio.
PEG (NY)7.44
PEG (5Y)4.13
EPS Next 2Y3.34%
EPS Next 3Y4.29%

6

5. GIN.DE Dividend Analysis

5.1 Amount

  • With a Yearly Dividend Yield of 2.46%, GIN has a reasonable but not impressive dividend return.
  • Compared to an average industry Dividend Yield of 2.29, GIN pays a bit more dividend than its industry peers.
  • GIN's Dividend Yield is a higher than the S&P500 average which is at 1.82.
Industry RankSector Rank
Dividend Yield 2.46%

5.2 History

  • The dividend of GIN has a limited annual growth rate of 2.57%.
Dividend Growth(5Y)2.57%
Div Incr Years0
Div Non Decr Years0

5.3 Sustainability

  • 58.96% of the earnings are spent on dividend by GIN. This is a bit on the high side, but may be sustainable.
  • The dividend of GIN is growing, but earnings are growing more, so the dividend growth is sustainable.
DP58.96%
EPS Next 2Y3.34%
EPS Next 3Y4.29%
GIN.DE Yearly Income VS Free CF VS DividendGIN.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B
GIN.DE Dividend Payout.GIN.DE Dividend Payout, showing the Payout Ratio.GIN.DE Dividend Payout.PayoutRetained Earnings

GIN.DE Fundamentals: All Metrics, Ratios and Statistics

GIVAUDAN-REG

FRA:GIN (1/23/2026, 7:00:00 PM)

3403

+4 (+0.12%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)01-29
Earnings (Next)04-14
Inst Owners35.71%
Inst Owner ChangeN/A
Ins Owners12.15%
Ins Owner ChangeN/A
Market Cap31.41B
Revenue(TTM)7.54B
Net Income(TTM)1.09B
Analysts74.29
Price Target4402.24 (29.36%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 2.46%
Yearly Dividend74.21
Dividend Growth(5Y)2.57%
DP58.96%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)2.61%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-0.17%
EPS NY rev (3m)-0.31%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.08%
Valuation
Industry RankSector Rank
PE 24.94
Fwd PE 23.44
P/S 3.82
P/FCF 25.91
P/OCF 19.89
P/B 7
P/tB N/A
EV/EBITDA 18.5
EPS(TTM)136.44
EY4.01%
EPS(NY)145.16
Fwd EY4.27%
FCF(TTM)131.33
FCFY3.86%
OCF(TTM)171.09
OCFY5.03%
SpS891.99
BVpS485.93
TBVpS-49.69
PEG (NY)7.44
PEG (5Y)4.13
Graham Number1221.37
Profitability
Industry RankSector Rank
ROA 9.7%
ROE 26.64%
ROCE 16.77%
ROIC 14.53%
ROICexc 15.06%
ROICexgc 33.58%
OM 18.93%
PM (TTM) 14.51%
GM 44.13%
FCFM 14.72%
ROA(3y)8.16%
ROA(5y)7.72%
ROE(3y)22.13%
ROE(5y)21.72%
ROIC(3y)11.27%
ROIC(5y)10.89%
ROICexc(3y)12.1%
ROICexc(5y)11.55%
ROICexgc(3y)26.29%
ROICexgc(5y)25.18%
ROCE(3y)13.01%
ROCE(5y)12.57%
ROICexgc growth 3Y11.26%
ROICexgc growth 5Y9.01%
ROICexc growth 3Y9.76%
ROICexc growth 5Y7.13%
OM growth 3Y4.7%
OM growth 5Y4.36%
PM growth 3Y6.18%
PM growth 5Y5.38%
GM growth 3Y1.09%
GM growth 5Y1.59%
F-Score8
Asset Turnover0.67
Health
Industry RankSector Rank
Debt/Equity 0.91
Debt/FCF 4.31
Debt/EBITDA 2.08
Cap/Depr 91.06%
Cap/Sales 4.46%
Interest Coverage 15.68
Cash Conversion 80.51%
Profit Quality 101.46%
Current Ratio 1.38
Quick Ratio 0.85
Altman-Z 4.47
F-Score8
WACC4.52%
ROIC/WACC3.21
Cap/Depr(3y)97.93%
Cap/Depr(5y)83.59%
Cap/Sales(3y)4.95%
Cap/Sales(5y)4.45%
Profit Quality(3y)99.97%
Profit Quality(5y)111.02%
High Growth Momentum
Growth
EPS 1Y (TTM)4.21%
EPS 3Y11.12%
EPS 5Y6.04%
EPS Q2Q%0.69%
EPS Next Y3.35%
EPS Next 2Y3.34%
EPS Next 3Y4.29%
EPS Next 5Y4.41%
Revenue 1Y (TTM)5.93%
Revenue growth 3Y3.51%
Revenue growth 5Y3.63%
Sales Q2Q%3.4%
Revenue Next Year1.48%
Revenue Next 2Y2.36%
Revenue Next 3Y3.19%
Revenue Next 5Y4.33%
EBIT growth 1Y12.19%
EBIT growth 3Y8.37%
EBIT growth 5Y8.14%
EBIT Next Year28.11%
EBIT Next 3Y11.5%
EBIT Next 5Y8.76%
FCF growth 1Y57.67%
FCF growth 3Y8.88%
FCF growth 5Y10.3%
OCF growth 1Y24.98%
OCF growth 3Y8.06%
OCF growth 5Y7.42%

GIVAUDAN-REG / GIN.DE FAQ

Can you provide the ChartMill fundamental rating for GIVAUDAN-REG?

ChartMill assigns a fundamental rating of 5 / 10 to GIN.DE.


Can you provide the valuation status for GIVAUDAN-REG?

ChartMill assigns a valuation rating of 3 / 10 to GIVAUDAN-REG (GIN.DE). This can be considered as Overvalued.


How profitable is GIVAUDAN-REG (GIN.DE) stock?

GIVAUDAN-REG (GIN.DE) has a profitability rating of 9 / 10.


Can you provide the financial health for GIN stock?

The financial health rating of GIVAUDAN-REG (GIN.DE) is 5 / 10.


What is the expected EPS growth for GIVAUDAN-REG (GIN.DE) stock?

The Earnings per Share (EPS) of GIVAUDAN-REG (GIN.DE) is expected to grow by 3.35% in the next year.